Collab Network
Our Collab Network members are not only experts within their own domain but educators with the research community. Learn more about the discoveries and findings our collaborators are achieving with IDT.
Member spotlight:
Manja Meggendorfer, PhD
The future of personalized genomics
Manja Meggendorfer is the Head of Molecular Genetics at Munich Leukemia Laboratory (MLL), where she oversees various R&D activities such as the 5,000 genome project, which is aimed at better understanding the genetic factors behind leukemia. She received her Master of Science in Biology from the Ludwig-Maximilians-University in Munich and her PhD. in collaboration with the Helmholtz Center Munich working on gene regulation within the architecture of the cell nucleus. After her post-doctorate, she moved to the field of hematology as a scientist in the department of molecular genetics at MLL. In combination with her MBA in Health Care Management, Manja hopes to improve the diagnostic and prognostic work associated with routine diagnostic approaches for leukemia or lymphoma patients.
Ultima Genomics
Unleash the power of genomics at scale
Ultima Genomics is unleashing the power of genomics at scale. The company's mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in genomic research. Ultima's revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists are forced to make between the breadth, depth, and frequency with which they use genomic information. Ultima Genomics’ novel massively parallel sequencing platform, the UG 100™, combines multiple innovative technologies, including an open flow cell design, a mostly natural chemistry that uses nucleotides without reversible terminators, and optical end-point detection, all to enable the sequencing of billions of reads with longer read lengths (~300 bp) and fast run times (<20 hrs) at high accuracy (Q30 > 85%) and a low cost of $1/Gb.